{"uri": "eng-9433678", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Diabetes", "type": "wiki", "score": 100, "label": {"eng": "Diabetes"}}, {"uri": "http://en.wikipedia.org/wiki/M\u00e9decins_Sans_Fronti\u00e8res", "type": "wiki", "score": 96, "label": {"eng": "M\u00e9decins Sans Fronti\u00e8res"}}, {"uri": "http://en.wikipedia.org/wiki/Semaglutide", "type": "wiki", "score": 88, "label": {"eng": "Semaglutide"}}, {"uri": "http://en.wikipedia.org/wiki/Novo_Nordisk", "type": "org", "score": 88, "label": {"eng": "Novo Nordisk"}}, {"uri": "http://en.wikipedia.org/wiki/Eli_Lilly_and_Company", "type": "org", "score": 81, "label": {"eng": "Eli Lilly and Company"}}, {"uri": "http://en.wikipedia.org/wiki/Insulin", "type": "wiki", "score": 80, "label": {"eng": "Insulin"}}, {"uri": "http://en.wikipedia.org/wiki/Developing_country", "type": "loc", "score": 77, "label": {"eng": "Developing country"}, "location": null}, {"uri": "http://en.wikipedia.org/wiki/Injector_pen", "type": "wiki", "score": 73, "label": {"eng": "Injector pen"}}, {"uri": "http://en.wikipedia.org/wiki/Dulaglutide", "type": "wiki", "score": 71, "label": {"eng": "Dulaglutide"}}, {"uri": "http://en.wikipedia.org/wiki/JAMA", "type": "wiki", "score": 65, "label": {"eng": "JAMA"}}, {"uri": "http://en.wikipedia.org/wiki/South_Africa", "type": "loc", "score": 57, "label": {"eng": "South Africa"}, "location": {"type": "country", "label": {"eng": "South Africa"}}}, {"uri": "http://en.wikipedia.org/wiki/World_Bank_high-income_economy", "type": "wiki", "score": 48, "label": {"eng": "World Bank high-income economy"}}, {"uri": "http://en.wikipedia.org/wiki/Glucagon-like_peptide-1", "type": "wiki", "score": 48, "label": {"eng": "Glucagon-like peptide-1"}}, {"uri": "http://en.wikipedia.org/wiki/Syringe", "type": "wiki", "score": 48, "label": {"eng": "Syringe"}}, {"uri": "http://en.wikipedia.org/wiki/Brazil", "type": "loc", "score": 41, "label": {"eng": "Brazil"}, "location": {"type": "country", "label": {"eng": "Brazil"}}}, {"uri": "http://en.wikipedia.org/wiki/India", "type": "loc", "score": 40, "label": {"eng": "India"}, "location": {"type": "country", "label": {"eng": "India"}}}, {"uri": "http://en.wikipedia.org/wiki/Latvia", "type": "loc", "score": 37, "label": {"eng": "Latvia"}, "location": {"type": "country", "label": {"eng": "Latvia"}}}, {"uri": "http://en.wikipedia.org/wiki/Intellectual_property", "type": "wiki", "score": 36, "label": {"eng": "Intellectual property"}}, {"uri": "http://en.wikipedia.org/wiki/Weight_loss", "type": "wiki", "score": 36, "label": {"eng": "Weight loss"}}, {"uri": "http://en.wikipedia.org/wiki/Corporation", "type": "wiki", "score": 33, "label": {"eng": "Corporation"}}, {"uri": "http://en.wikipedia.org/wiki/Pharmaceutical_industry", "type": "wiki", "score": 32, "label": {"eng": "Pharmaceutical industry"}}, {"uri": "http://en.wikipedia.org/wiki/Pharmacist", "type": "wiki", "score": 28, "label": {"eng": "Pharmacist"}}, {"uri": "http://en.wikipedia.org/wiki/United_States_dollar", "type": "wiki", "score": 28, "label": {"eng": "United States dollar"}}, {"uri": "http://en.wikipedia.org/wiki/License", "type": "wiki", "score": 25, "label": {"eng": "License"}}, {"uri": "http://en.wikipedia.org/wiki/World_Health_Organization", "type": "wiki", "score": 25, "label": {"eng": "World Health Organization"}}, {"uri": "http://en.wikipedia.org/wiki/Philippines", "type": "loc", "score": 24, "label": {"eng": "Philippines"}, "location": {"type": "country", "label": {"eng": "Philippines"}}}, {"uri": "http://en.wikipedia.org/wiki/Health_care", "type": "wiki", "score": 17, "label": {"eng": "Health care"}}, {"uri": "http://en.wikipedia.org/wiki/Insulin_analog", "type": "wiki", "score": 12, "label": {"eng": "Insulin analog"}}], "eventDate": "2024-03-27", "totalArticleCount": 5, "title": {"eng": "'Huge markup on prices of new diabetes medicines and insulin pens' - Times of India"}, "summary": {"eng": "A new study in the Journal of the American Medical Association (JAMA) Network Open suggests exorbitant corporate profiteering on newer diabetes medicines and insulin pen devices, making them inaccessible for diabetics particularly in low-and middle-income countries.\n\nThe study by international medical humanitarian agency, M\u00e9decins Sans Fronti\u00e8res (MSF), if acted upon by policymakers, governments and procurers, could have a major impact on the affordability of diabetes therapies.\n\nA key finding "}, "location": null, "categories": [{"uri": "dmoz/Society/Issues/Health", "label": "dmoz/Society/Issues/Health", "wgt": 100}, {"uri": "dmoz/Health/Specific_Substances/Tobacco", "label": "dmoz/Health/Specific Substances/Tobacco", "wgt": 100}, {"uri": "dmoz/Health/Teen_Health/Drugs_and_Alcohol", "label": "dmoz/Health/Teen Health/Drugs and Alcohol", "wgt": 100}, {"uri": "news/Health", "label": "news/Health", "wgt": 79}], "articleCounts": {"eng": 5}, "sentiment": 0.09019607843137245, "wgt": 449193600, "relevance": 1}